Y
The startup is developing a platform that utilizes small molecule compounds to induce neural stem cells for the treatment of chronic spinal cord injuries. This technology aims to enable clinicians to provide targeted cell therapy, addressing the significant limitations in current treatment options for patients with spinal cord damage.
Seoul, South Korea
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup is developing a platform that utilizes small molecule compounds to induce neural stem cells for the treatment of chronic spinal cord injuries. This technology aims to enable clinicians to provide targeted cell therapy, addressing the significant limitations in current treatment options for patients with spinal cord damage.